0002067551-26-000001.txt : 20260720 0002067551-26-000001.hdr.sgml : 20260720 20260720113250 ACCESSION NUMBER: 0002067551-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260720 DATE AS OF CHANGE: 20260720 EFFECTIVENESS DATE: 20260720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anavatos Bio Inc. CENTRAL INDEX KEY: 0002067551 ORGANIZATION NAME: EIN: 333115720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-545657 FILM NUMBER: 261185753 BUSINESS ADDRESS: STREET 1: 2314 NORTH 46TH STREET CITY: SEATTLE STATE: WA ZIP: 98103 BUSINESS PHONE: 206 437 3169 MAIL ADDRESS: STREET 1: 2314 NORTH 46TH STREET CITY: SEATTLE STATE: WA ZIP: 98103 D/A 1 primary_doc.xml X0708 D/A LIVE 0002067551 Anavatos Bio Inc. 2314 NORTH 46TH STREET SEATTLE WA WASHINGTON 98103 206 437 3169 DELAWARE None None Corporation true 2025 Leah Klein 2314 North 46th Street Seattle WA WASHINGTON 98103 Executive Officer Biotechnology Decline to Disclose 06b true 0002067551-25-000001 2025-04-27 true true true Simple Agreement for Future Equity false 2500 Indefinite 392500 Indefinite false 4 0 0 0 Proceeds are for working capital. The number above excludes use of proceeds for normal salary and bonus to executive officers. false Anavatos Bio Inc. Leah C. Klein Leah C. Klein CEO 2026-07-20